SCHEMBL7797300

SCHEMBL7797300

CCCCCCCCCCCCSCC(O)COCCCCCCCCCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.61
HTT P42858 2/20 0.59
LPAR5 Q9H1C0 4/20 0.51
PLA2G4B P0C869 1/20 0.49
SPHK1 Q9NYA1 1/20 0.46
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
PRKD3 O94806 2/20 0.41
PRKCG P05129 2/20 0.41
PRKCB P05771 2/20 0.41
PRKCA P17252 2/20 0.41
PRKCH P24723 2/20 0.41
PRKCI P41743 2/20 0.41
PRKCE Q02156 2/20 0.41
PRKCQ Q04759 2/20 0.41
PRKCZ Q05513 2/20 0.41
PRKCD Q05655 2/20 0.41
PRKD1 Q15139 2/20 0.41
LPAR1 Q92633 6/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11739224 1.00 USP2 (0.61) USP2HTTLPAR5PLA2G4BSPHK1
SCHEMBL11738017 1.00 USP2 (0.61) USP2HTTLPAR5PLA2G4BSPHK1
SCHEMBL11734597 1.00 USP2 (0.61) USP2HTTLPAR5PLA2G4BSPHK1
SCHEMBL11580806 1.00 USP2 (0.61) USP2HTTLPAR5PLA2G4BSPHK1
SCHEMBL11734142 1.00 USP2 (0.61) USP2HTTLPAR5PLA2G4BSPHK1
SCHEMBL11580000 1.00 USP2 (0.61) USP2HTTLPAR5PLA2G4BSPHK1
SCHEMBL11735424 1.00 USP2 (0.61) USP2HTTLPAR5PLA2G4BSPHK1
SCHEMBL11737279 0.97 USP2 (0.56) USP2HTTLPAR5PLA2G4BSPHK1
SCHEMBL11734486 0.97 USP2 (0.56) USP2HTTLPAR5PLA2G4BSPHK1
SCHEMBL11741330 0.97 USP2 (0.56) USP2HTTLPAR5PLA2G4BSPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177469-B1 ANTIUTOR AGENTS; AUTOIMMUNE DISEASES HEIDELBERG PHARMA HOLDING GMBH (DE) 2001-01-23 US claimed
EP-0854708-B1 LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS HEIDELBERG PHARMA HOLDING GMBH (DE) 2001-12-12 EP disclosed
US-6177469-B1 ANTIUTOR AGENTS; AUTOIMMUNE DISEASES HEIDELBERG PHARMA HOLDING GMBH (DE) 2001-01-23 US disclosed
EP-0854708-A1 LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS Roche Diagnostics GmbH (DE) 1998-07-29 EP disclosed
WO-1997014410-A1 LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS BOEHRINGER MANNHEIM GMBH (DE) 1997-04-24 WO disclosed
EP-0416401-B1 Use of derivatives of phospholipides as antiviral pharmaceuticals and phospholipides BOEHRINGER MANNHEIM GMBH (DE) 1996-10-30 EP disclosed
US-5158942-A PROCESS OF USING PHOSPHOLIPID DERIVATIVES TO INHIBIT MULTIPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS BOEHRINGER MANNHEIM GMBH (DE) 1992-10-27 US disclosed
EP-0416401-A2 Use of derivatives of phospholipides as antiviral pharmaceuticals and phospholipides Roche Diagnostics GmbH (DE) 1991-03-13 EP disclosed